These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26028371)

  • 1. Prognostic factors and outcome analysis of salivary duct carcinoma.
    Han MW; Roh JL; Choi SH; Nam SY; Lee HJ; Cho KJ; Lee SW; Kim SY
    Auris Nasus Larynx; 2015 Dec; 42(6):472-7. PubMed ID: 26028371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
    Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
    Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
    Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
    Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
    Monteiro LS; Bento MJ; Palmeira C; Lopes C
    J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary duct carcinoma: what is already known, and can we improve survival?
    Wee DT; Thomas AA; Bradley PJ
    J Laryngol Otol; 2012 Jul; 126 Suppl 2():S2-7. PubMed ID: 22495125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival analysis and immunohistochemical study of HER-2 and AR (androgen receptor) expression in salivary duct carcinoma].
    Otsuka K; Imanishi Y; Habu N; Sato Y; Shigetomi S; Fujii R; Sakamoto K; Tomita T; Fujii M; Kameyama K; Ogawa K
    Nihon Jibiinkoka Gakkai Kaiho; 2013 Sep; 116(9):1024-32. PubMed ID: 24191589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid salivary duct carcinoma: a single institution's 20-year experience.
    Stodulski D; Mikaszewski B; Majewska H; Kuczkowski J
    Eur Arch Otorhinolaryngol; 2019 Jul; 276(7):2031-2038. PubMed ID: 31062093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.
    Masubuchi T; Tada Y; Maruya S; Osamura Y; Kamata SE; Miura K; Fushimi C; Takahashi H; Kawakita D; Kishimoto S; Nagao T
    Int J Clin Oncol; 2015 Feb; 20(1):35-44. PubMed ID: 24553861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
    Nabili V; Tan JW; Bhuta S; Sercarz JA; Head CS
    Head Neck; 2007 Oct; 29(10):907-12. PubMed ID: 17563907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncocytic carcinoma of the salivary glands: A Danish national study.
    Westergaard-Nielsen M; Godballe C; Andersen LJ; Primdahl H; Kristensen CA; Andersen E; Bjørndal K
    Auris Nasus Larynx; 2018 Aug; 45(4):825-830. PubMed ID: 29100750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic analysis of adenoid cystic carcinoma of major salivary glands of 64 cases].
    Qing J; Zhang Q; Wei MW; Guo ZM
    Ai Zheng; 2006 Sep; 25(9):1138-43. PubMed ID: 16965658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.
    Mayer M; Wolber P; Prinz J; Jansen L; Esser J; Shabli S; Quaas A; Klußmann JP; Sharma SJ; Nachtsheim L; Arolt C
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3779-3789. PubMed ID: 38587651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
    Yamamoto H; Uryu H; Segawa Y; Tsuneyoshi M
    Pathol Int; 2008 May; 58(5):322-6. PubMed ID: 18429833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
    Cornolti G; Ungari M; Morassi ML; Facchetti F; Rossi E; Lombardi D; Nicolai P
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD; Roberts D; Blumenschein GR; Temam S; Kies MS; Rosenthal DI; Weber RS; El-Naggar AK
    Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of cervical lymph node metastasis in salivary gland cancer.
    Ettl T; Gosau M; Brockhoff G; Schwarz-Furlan S; Agaimy A; Reichert TE; Rohrmeier C; Zenk J; Iro H
    Head Neck; 2014 Apr; 36(4):517-23. PubMed ID: 23780687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical correlation of epidermal growth factor receptor and c-erbB-2 with histopathologic grading of mucoepidermoid carcinoma.
    Khiavi MM; Vosoughhosseini S; Saravani S; Halimi M
    J Cancer Res Ther; 2012; 8(4):586-90. PubMed ID: 23361279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review.
    Uijen MJM; Lassche G; van Engen-van Grunsven ACH; Tada Y; Verhaegh GW; Schalken JA; Driessen CML; van Herpen CML
    Cancer Treat Rev; 2020 Sep; 89():102069. PubMed ID: 32717621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.